Development of an IL-6 Inhibitor Based on the Functional Analysis of Murine IL-6Rα1

Chemistry and Biology

Volumn 16, Issue 7, 2009, Pages 783-794

  Wiesinger, Monique Y ^a   Haan, Serge ^b   Wüller, Stefan ^a   Kauffmann, Maria Elisabeth ^a   Recker, Tobias ^a   Küster, Andrea ^a   Heinrich, Peter C ^c   Müller Newen, Gerhard ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Faculté des Sciences   (Luxembourg)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CELLBIO; CHEMBIO; MOLIMMUNO

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIGAND;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG DESIGN; GENETICS; INFLAMMATION; METHODOLOGY; MOUSE; MUTATION; PROTEIN ENGINEERING;

ANIMALS; DRUG DESIGN; INFLAMMATION; INTERLEUKIN-6; LIGANDS; MICE; MUTATION; PROTEIN ENGINEERING; RECEPTORS, INTERLEUKIN-6;

MURINAE;

EID: 67651114018     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.06.010     Document Type: Article

References (35)

1. Ancey C., Küster A., Haan S., Herrmann A., Heinrich P.C., and Müller-Newen G. A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor. J. Biol. Chem. 278 (2003) 16968-16972
2. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
3. Arcone R., Pucci P., Zappacosta F., Fontaine V., Malorni A., Marino G., and Ciliberto G. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur. J. Biochem. 198 (1991) 541-547
4. Bettelli E., Korn T., Oukka M., and Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 453 (2008) 1051-1057
5. Boulanger M.J., Chow D., Brevnova E.E., and Garcia K.C. Hexameric structure and assembly of the interleukin-6/IL-6a-receptor/gp130 complex. Science 300 (2003) 2101-2104
6. Economides A.N., Carpenter L.R., Rudge J.S., Wong V., Koehler-Stec E.M., Hartnett C., Pyles E.A., Xu X., Daly T.J., Young M.R., et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 9 (2003) 47-52
7. Fehrenbach H., Weiskirchen R., Kasper M., and Gressner A.M. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 34 (2001) 943-952
8. Goldenberg M.M. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin. Ther. 21 (1999) 75-87
9. Grötzinger J., Kurapkat G., Wollmer A., Kalai M., and Rose-John S. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins 27 (1997) 96-109
10. Hansen G., Hercus T.R., McClure B.J., Stomski F.C., Dottore M., Powell J., Ramshaw H., Woodcock J.M., Xu Y., Guthridge M., et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134 (2008) 496-507
11. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
12. Hilton D.J., Hilton A.A., Raicevic A., Rakar S., Harrison-Smith M., Gough N.M., Begley C.G., Metcalf D., Nicola N.A., and Willson T.A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13 (1994) 4765-4775
13. Horsten U., Schmitz-Van de Leur H., Müllberg J., Heinrich P.C., and Rose-John S. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor. FEBS Lett. 360 (1995) 43-46
14. Ishihara K., and Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13 (2002) 357-368
15. LaSpina M., Tripathi S., Gatto L.A., Bruch D., Maier K.G., and Kittur D.S. An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice. J. Surg. Res. 148 (2008) 121-125
16. Levine S.J. Mechanisms of soluble cytokine receptor generation. J. Immunol. 173 (2004) 5343-5348
17. Lu Z.Y., Brochier J., Wijdenes J., Brailly H., Bataille R., and Klein B. High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur. J. Immunol. 22 (1992) 2819-2824
18. Metz S., Wiesinger M., Vogt M., Lauks H., Schmalzing G., Heinrich P.C., and Müller-Newen G. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins. J. Biol. Chem. 282 (2007) 1238-1248
19. Metz S., Naeth G., Heinrich P.C., and Müller-Newen G. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors. J. Biol. Chem. 283 (2008) 5985-5995
20. Müller-Newen G. The cytokine receptor gp130: faithfully promiscuous. Sci. STKE 2003 (2003) pe40
21. Müller-Newen G., Küster A., Hemmann U., Keul R., Horsten U., Martens A., Graeve L., Wijdenes J., and Heinrich P.C. Soluble interleukin-6 receptor potentiates the antagonistic activity of soluble gp130 on interleukin-6 responses. J. Immunol. 161 (1998) 6347-6355
22. Naugler W.E., and Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 14 (2008) 109-119
23. Scheller J., Ohnesorge N., and Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol. 63 (2006) 321-329
24. Schuster B., Kovaleva M., Sun Y., Regenhard P., Matthews V., Grotzinger J., Rose-John S., and Kallen K.J. Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J. Biol. Chem. 278 (2003) 9528-9535
25. Sepulveda P., Encabo A., Carbonell-Uberos F., and Minana M.D. BCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34+ hematopoietic cells. Cell Death Differ. 14 (2007) 378-380
26. Serada S., Fujimoto M., Mihara M., Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa T., Terabe F., Ohkawara T., et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105 (2008) 9041-9046
27. Staunton D., Hudson K.R., and Heath J.K. The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: implications for receptor complex formation. Protein Eng. 11 (1998) 1093-1102
28. Vaccaro C., Zhou J., Ober R.J., and Ward E.S. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat. Biotechnol. 23 (2005) 1283-1288
29. Varghese J.N., Moritz R.L., Lou M.Z., Van Donkelaar A., Ji H., Ivancic N., Branson K.M., Hall N.E., and Simpson R.J. Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain. Proc. Natl. Acad. Sci. USA 99 (2002) 15959-15964
30. Vollmer P., Oppmann B., Voltz N., Fischer M., and Rose-John S. A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding. Eur. J. Biochem. 263 (1999) 438-446
31. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8 (1990) 52-56
32. Wagner B.J., Hayes T.E., Hoban C.J., and Cochran B.H. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9 (1990) 4477-4484
33. Wegenka U.M., Lütticken C., Buschmann J., Yuan J., Lottspeich F., Müller-Esterl W., Schindler C., Roeb E., Heinrich P.C., and Horn F. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transduction and transcription (Stat) factor family. Mol. Cell. Biol. 14 (1994) 3186-3196
34. Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Lai K.B., Lee C.N., and Hsieh C.Y. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22 (2003) 1517-1527
35. Weiergräber O., Hemmann U., Küster A., Müller-Newen G., Schneider J., Rose-John S., Kurschat P., Brakenhoff J.P., Hart M.H., Stabel S., and Heinrich P.C. Soluble human interleukin-6 receptor: expression in insect cells, purification and characterization. Eur. J. Biochem. 234 (1995) 661-669